title: Copper that cancer with lysosomal love!
authors.affiliation: Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, The University of Sydney, New South Wales, 2006, Australia.
authors.forename: Zaklina
authors.initials: Z
authors.lastname: Kovacevic
authors.affiliation: Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, The University of Sydney, New South Wales, 2006, Australia.
authors.forename: Sumit
authors.initials: S
authors.lastname: Sahni
authors.affiliation: Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, The University of Sydney, New South Wales, 2006, Australia.
authors.forename: Des R
authors.initials: DR
authors.lastname: Richardson
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002614:Chelating Agents / Q000494:pharmacology*; D003300:Copper; D006801:Humans; D008247:Lysosomes / Q000187:drug effects*; D009369:Neoplasms; D013882:Thiosemicarbazones / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D002614:Chelating Agents; D013882:Thiosemicarbazones; C539263:di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone; D003300:Copper
keywords: Dp44mT; DpC; P-glycoprotein; cancer; drug resistance